Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 111

1.

Receptor Crosslinking in Drug Delivery: Detour to the Lysosome?

Ogris M, Sami H.

Mol Ther. 2015 Dec;23(12):1802-4. doi: 10.1038/mt.2015.207. No abstract available.

PMID:
26689121
2.

Simultaneous determination of active component and vehicle penetration from F-DPPC liposomes into porcine skin layers.

Mahrhauser DS, Reznicek G, Gehrig S, Geyer A, Ogris M, Kieweler R, Valenta C.

Eur J Pharm Biopharm. 2015 Nov;97(Pt A):90-5. doi: 10.1016/j.ejpb.2015.10.008. Epub 2015 Oct 19.

PMID:
26493713
3.

Assessment of Raman spectroscopy as a fast and non-invasive method for total stratum corneum thickness determination of pig skin.

Mahrhauser DS, Nagelreiter C, Gehrig S, Geyer A, Ogris M, Kwizda K, Valenta C.

Int J Pharm. 2015 Nov 10;495(1):482-4. doi: 10.1016/j.ijpharm.2015.09.018. Epub 2015 Sep 14.

PMID:
26383843
4.

Evaluation of improved PAMAM-G5 conjugates for gene delivery targeted to the transferrin receptor.

Urbiola K, Blanco-Fernández L, Navarro G, Rödl W, Wagner E, Ogris M, Tros de Ilarduya C.

Eur J Pharm Biopharm. 2015 Aug;94:116-22. doi: 10.1016/j.ejpb.2015.05.007. Epub 2015 May 22.

PMID:
26004821
5.

Gene therapy and imaging in preclinical and clinical oncology: recent developments in therapy and theranostics.

Gehrig S, Sami H, Ogris M.

Ther Deliv. 2014 Dec;5(12):1275-96. doi: 10.4155/tde.14.87. Review.

PMID:
25531929
6.

The stem cell factor SOX2 regulates the tumorigenic potential in human gastric cancer cells.

Hütz K, Mejías-Luque R, Farsakova K, Ogris M, Krebs S, Anton M, Vieth M, Schüller U, Schneider MR, Blum H, Wagner E, Jung A, Gerhard M.

Carcinogenesis. 2014 Apr;35(4):942-50. doi: 10.1093/carcin/bgt410. Epub 2013 Dec 9.

7.

Gene therapy in the clinics: shifting into the next gear.

Ogris M.

Ther Deliv. 2013 Nov;4(11):1359-63. doi: 10.4155/tde.13.109. No abstract available.

PMID:
24228987
8.

EGFR-Targeted Adenovirus Dendrimer Coating for Improved Systemic Delivery of the Theranostic NIS Gene.

Grünwald GK, Vetter A, Klutz K, Willhauck MJ, Schwenk N, Senekowitsch-Schmidtke R, Schwaiger M, Zach C, Wagner E, Göke B, Holm PS, Ogris M, Spitzweg C.

Mol Ther Nucleic Acids. 2013 Nov 5;2:e131. doi: 10.1038/mtna.2013.58.

9.

Systemic image-guided liver cancer radiovirotherapy using dendrimer-coated adenovirus encoding the sodium iodide symporter as theranostic gene.

Grünwald GK, Vetter A, Klutz K, Willhauck MJ, Schwenk N, Senekowitsch-Schmidtke R, Schwaiger M, Zach C, Wagner E, Göke B, Holm PS, Ogris M, Spitzweg C.

J Nucl Med. 2013 Aug;54(8):1450-7. doi: 10.2967/jnumed.112.115493. Epub 2013 Jul 10.

10.

De-targeting by miR-143 decreases unwanted transgene expression in non-tumorigenic cells.

Kopp F, Schnoedt M, Haase R, Wagner E, Roidl A, Ogris M.

Gene Ther. 2013 Nov;20(11):1104-9. doi: 10.1038/gt.2013.37. Epub 2013 Jun 27.

PMID:
23804075
11.
12.

Generation of a tumor- and tissue-specific episomal non-viral vector system.

Haase R, Magnusson T, Su B, Kopp F, Wagner E, Lipps H, Baiker A, Ogris M.

BMC Biotechnol. 2013 Jun 4;13:49. doi: 10.1186/1472-6750-13-49.

13.

Gene therapy for advanced melanoma: selective targeting and therapeutic nucleic acids.

Viola JR, Rafael DF, Wagner E, Besch R, Ogris M.

J Drug Deliv. 2013;2013:897348. doi: 10.1155/2013/897348. Epub 2013 Mar 25.

14.

Targeted therapy of cancer stem cells: science or fiction.

Ogris M, Roidl A.

Ther Deliv. 2013 Feb;4(2):135-8. doi: 10.4155/tde.12.153. No abstract available.

PMID:
23343151
15.

In vivo imaging enables high resolution preclinical trials on patients' leukemia cells growing in mice.

Terziyska N, Castro Alves C, Groiss V, Schneider K, Farkasova K, Ogris M, Wagner E, Ehrhardt H, Brentjens RJ, zur Stadt U, Horstmann M, Quintanilla-Martinez L, Jeremias I.

PLoS One. 2012;7(12):e52798. doi: 10.1371/journal.pone.0052798. Epub 2012 Dec 31.

16.

Systemic TNFα gene therapy synergizes with liposomal doxorubicine in the treatment of metastatic cancer.

Su B, Cengizeroglu A, Farkasova K, Viola JR, Anton M, Ellwart JW, Haase R, Wagner E, Ogris M.

Mol Ther. 2013 Feb;21(2):300-8. doi: 10.1038/mt.2012.229. Epub 2012 Nov 13.

17.

Adenoviral vectors coated with PAMAM dendrimer conjugates allow CAR independent virus uptake and targeting to the EGF receptor.

Vetter A, Virdi KS, Espenlaub S, Rödl W, Wagner E, Holm PS, Scheu C, Kreppel F, Spitzweg C, Ogris M.

Mol Pharm. 2013 Feb 4;10(2):606-18. doi: 10.1021/mp300366f. Epub 2013 Jan 18.

PMID:
23281933
18.

Synthesis of polyethylenimine-based nanocarriers for systemic tumor targeting of nucleic acids.

Rödl W, Schaffert D, Wagner E, Ogris M.

Methods Mol Biol. 2013;948:105-20. doi: 10.1007/978-1-62703-140-0_8.

PMID:
23070766
19.

SiRNA therapeutics: chances, pitfalls and future potential.

Ogris M, Schaffert D.

Ther Deliv. 2011 Sep;2(9):1101-4. No abstract available.

PMID:
22833907
20.

Porcine ear necrosis syndrome: a preliminary investigation of putative infectious agents in piglets and mycotoxins in feed.

Weissenbacher-Lang C, Voglmayr T, Waxenecker F, Hofstetter U, Weissenböck H, Hoelzle K, Hoelzle LE, Welle M, Ogris M, Bruns G, Ritzmann M.

Vet J. 2012 Dec;194(3):392-7. doi: 10.1016/j.tvjl.2012.05.026. Epub 2012 Jul 10.

PMID:
22784419
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk